Benzinga's Top Pre-Market Gainers
Integramed America Inc (NASDAQ: INMD) surged 21.60% to $13.79 in the pre-market session. IntegraMed agreed to be bought by Sagard Capital Partners for $14.05 per share in cash.
Ampio Pharmaceuticals Inc (NASDAQ: AMPE) rose 10.94% to $3.55 in the pre-market trading. AMPE reported positive clinical trial results for the treatment of diabetic macular edema with orally administered Optina.
Dean Foods Company (NYSE: DF) moved up 4.93% to $16.81 in the pre-market session. DF's PEG ratio is 1.04.
Nabors Industries Ltd (NYSE: NBR) gained 3.96% to $13.90 in the pre-market session. NBR's trailing-twelve-month revenue is $6.58 billion.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.